Skip to content
Menu

HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $18

Benzinga Newsdesk 11 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $16 to $18.

HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $16 to $18.

Read at benzinga.com

← All stock news